Ryu Sujin, Park Ki Moon, Lee Seung Ho
Department of Nano-Bioengineering, Incheon National University, 119 Academy-ro, Yeonsu-gu, Incheon 406-772, Korea.
Department of Food Science and Biotechnology, Sungkyunkwan University, Seoul 440-746, Korea.
Int J Mol Sci. 2016 Mar 2;17(3):328. doi: 10.3390/ijms17030328.
Gleditsia sinensis thorns (GST) have been used as a traditional medicine for carbuncles and skin diseases. The purpose of this study was to decide whether non-toxicological levels of water extract of GST (WEGST) are effective in inhibiting the progress of prostate cancer formation and to identify the target molecule involved in the WEGST-mediated inhibitory process of prostate cancer cell migration and in vivo tumor formation. Through the Boyden chamber migration assay, we found that non-toxic levels of WEGST could not attenuate the PC3 migration to the bottom area coated with serum but significantly inhibited PC3 cell migration to the collagen-coated bottom area. We also found that non-toxic levels of WEGST significantly attenuated collagen against adhesion. Interestingly, ectopic administration of WEGST could not affect the expression of α2β1 integrin, which is known as a receptor of collagen. However, when the PC3 cells adhered to a collagen-coated plate, the expression of α2 integrin but not that of β1 integrin was significantly inhibited by the administration of non-toxic levels of WEGST, leading to the inhibition of focal adhesion kinase (FAK) phosphorylation. Furthermore, oral administration of WEGST (25 mg/kg/day) significantly inhibited the size of a PC3 cell-xenografted tumor. Taken together, these results suggest a novel molecular mechanism for WEGST to inhibit prostate cancer progression at particular stages, such as collagen-mediated adhesion and migration, and it might provide further development for the therapeutic use of WEGST in the treatment of prostate cancer progression.
皂角刺一直被用作治疗痈肿和皮肤病的传统药物。本研究的目的是确定无毒剂量的皂角刺水提取物(WEGST)是否能有效抑制前列腺癌的形成进程,并确定参与WEGST介导的前列腺癌细胞迁移和体内肿瘤形成抑制过程的靶分子。通过博伊登小室迁移实验,我们发现无毒剂量的WEGST不能减弱PC3细胞向涂有血清的底部区域的迁移,但能显著抑制PC3细胞向胶原包被的底部区域的迁移。我们还发现无毒剂量的WEGST能显著减弱胶原介导的黏附。有趣的是,异位给予WEGST不影响α2β1整合素的表达,α2β1整合素是已知的胶原受体。然而,当PC3细胞黏附于胶原包被的平板时,无毒剂量的WEGST给药能显著抑制α2整合素而非β1整合素的表达,导致黏着斑激酶(FAK)磷酸化受到抑制。此外,口服WEGST(25mg/kg/天)能显著抑制PC3细胞异种移植瘤的大小。综上所述,这些结果提示了WEGST在特定阶段抑制前列腺癌进展的新分子机制,如胶原介导的黏附和迁移,这可能为WEGST在前列腺癌进展治疗中的应用提供进一步的发展方向。